Risk factors related to the SARS-CoV-2 vaccine additional doses hesitancy among pregnant and non-pregnant people of reproductive age and partners: A Brazilian cross-sectional study.
COVID‐19
non‐pregnant people
predictors
pregnant people
vaccine acceptance
vaccine hesitancy
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
26 Mar 2024
26 Mar 2024
Historique:
revised:
09
03
2024
received:
26
01
2024
accepted:
18
03
2024
medline:
27
3
2024
pubmed:
27
3
2024
entrez:
27
3
2024
Statut:
aheadofprint
Résumé
The aim of this study was to assess the predictors of acceptance and hesitancy of additional doses of any SARS-CoV-2 (COVID-19) vaccine among pregnant or recently pregnant and non-pregnant people of reproductive age and partners in Brazil. We conducted an online cross-sectional study from June 2022 to April 2023 and invited women and partners between 18 and 49 years old to participate. We employed a snowball strategy to reach all potential eligible participants. Our primary outcome was the acceptance rate of the COVID-19 booster vaccine. We estimated the frequency and percentage for the three groups and compared categorical variables using the Chi-square test. Moreover, bivariate, backward stepwise regression, and subgroup analyses were performed to evaluate risk factors and predictors of COVID-19 vaccine booster hesitancy. We reported the effect size as OR with a 95% CI. We included 1487 participants, and among them, 334 (22.5%) were pregnant or recently pregnant people, 905 (60.8%) were non-pregnant people, and 247 (16.6%) were male partners. Pregnant and recently pregnant people showed greater hesitancy for the COVID-19 vaccine booster than non-pregnant people (28% vs 15%, P < 0.001) and male partners (28% vs 16%, P < 0.001). Non-pregnant women accepted the COVID-19 vaccine more often than pregnant or recently pregnant people (OR 1.75; 95% CI: 1.13-2.70). The associated factors to the reduced COVID-19 vaccine booster acceptance were family income between US$ 566-945.00 (54%), evangelic religion (65%), concern about vaccine safety (80%) and perceived common vaccine importance (93%). Pregnant people were more hesitant than non-pregnant people to accept the COVID-19 booster vaccine. Family income, religious beliefs, vaccine safety concerns, and perceived common vaccine importance were significant barriers to accepting COVID-19 booster vaccines. The impact of these factors was more evident among pregnant or recently pregnant people, emphasizing the harmful effect of misinformation among this vulnerable population.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : SRH, part of the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organisation (WHO)
Informations de copyright
© 2024 International Federation of Gynecology and Obstetrics.
Références
Xavier DR, Lima e Silva E, Lara FA, et al. Involvement of political and socio‐economic factors in the spatial and temporal dynamics of COVID‐19 outcomes in Brazil: a population‐based study. Lancet Reg Health Am. 2022;10:100221. doi:10.1016/j.lana.2022.100221
Siqueira TS, Silva JRS, Souza MDR, et al. Spatial clusters, social determinants of health and risk of maternal mortality by COVID‐19 in Brazil: a national population‐based ecological study. Lancet Reg Health Am. 2021;3:100076. doi:10.1016/j.lana.2021.100076
Maza‐Arnedo F, Paternina‐Caicedo A, Sosa CG, et al. Maternal mortality linked to COVID‐19 in Latin America: results from a multi‐country collaborative database of 447 deaths. Lancet Reg Health Am. 2022;12:100269. doi:10.1016/j.lana.2022.100269
Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of COVID‐19, SARS‐CoV‐2 transmission, and COVID‐19 mortality: systematic review and meta‐analysis. BMJ. 2021;375:e068302. doi:10.1136/bmj-2021-068302
World Health Organization. Considerations in Adjusting Public Health and Social Measures in the Context of COVID‐19: Interim Guidance. World Health Organization; 2013. https://www.who.int/publications/i/item/who‐2019‐ncov‐adjusting‐ph‐measures‐2023.1
Alakija A. Leveraging lessons from the COVID‐19 pandemic to strengthen low‐income and middle‐income country preparedness for future global health threats. Lancet Infect Dis. 2023;23:e310‐e317. doi:10.1016/S1473-3099(23)00279-7
Schurer S, Atalay K, Glozier N, Vera‐Toscano E, Wooden M. Quantifying the human impact of Melbourne's 111‐day hard lockdown experiment on the adult population. Nat Hum Behav. 2023;7:1652‐1666. doi:10.1038/s41562-023-01638-1
Minchin J, Harris GH, Baumann S, Smith ER. Exclusion of pregnant people from emergency vaccine clinical trials: a systematic review of clinical trial protocols and reporting from 2009 to 2019. Vaccine. 2023;41:5159‐5181. doi:10.1016/j.vaccine.2023.06.073
Taylor MM, Kobeissi L, Kim C, et al. Inclusion of pregnant women in COVID‐19 treatment trials: a review and global call to action. Lancet Glob Health. 2021;9:e366‐e371. doi:10.1016/S2214-109X(20)30484-8
The Lancet. COVID‐19 in Brazil: “so what?”. Lancet. 2020;395:1461. doi:10.1016/S0140-6736(20)31095-3
Alves L. Vaccination against all odds in Brazil. Lancet Child Adolesc Health. 2022;6:362. doi:10.1016/S2352-4642(22)00094-3
Barberia LG, Boing A, Santana L, Cota W, Bastos LS. Government inaction on COVID‐19 vaccines contributes to the persistence of childism in Brazil. Lancet Reg Health Am. 2022;13:100346. doi:10.1016/j.lana.2022.100346
Chan MS, Albarracín D. A meta‐analysis of correction effects in science‐relevant misinformation. Nat Hum Behav. 2023;7:1514‐1525. doi:10.1038/s41562-023-01623-8
MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161‐4164. doi:10.1016/j.vaccine.2015.04.036
Friedrich MJ. WHO's top health threats for 2019. JAMA. 2019;321:1041. doi:10.1001/jama.2019.1934
World Health Organization. Brazil: WHO Coronavirus D Ase (COVID‐19) Dashboard with Vaccination Data. WHO; 2023.
Teixeira AMS, Domingues CMAS. Rapid monitoring of vaccination coverage following vaccination campaigns in Brazil: 2008, 2011 and 2012. Epidemiol Serv Saúde. 2013;22:565‐578. doi:10.5123/S1679-49742013000400003
Lotta G, Fernandez M, Kuhlmann E, Wenham C. COVID‐19 vaccination challenge: what have we learned from the Brazilian process? Lancet Glob Health. 2022;10:e613‐e614. doi:10.1016/S2214-109X(22)00049-3
Kanyanda S, Markhof Y, Wollburg P, Zezza A. Acceptance of COVID‐19 vaccines in sub‐Saharan Africa: evidence from six national phone surveys. BMJ Open. 2021;11:e055159. doi:10.1136/bmjopen-2021-055159
Skjefte M, Ngirbabul M, Akeju O, et al. COVID‐19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36:197‐211. doi:10.1007/s10654-021-00728-6
Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Uptake of COVID‐19 vaccines among pregnant women: a systematic review and meta‐analysis. Vaccines (Basel). 2022;10:766. doi:10.3390/vaccines10050766
Bhattacharya O, Siddiquea BN, Shetty A, Afroz A, Billah B. COVID‐19 vaccine hesitancy among pregnant women: a systematic review and meta‐analysis. BMJ Open. 2022;12:e061477. doi:10.1136/bmjopen-2022-061477
Rubin R. Pregnant People's paradox‐excluded from vaccine trials despite having a higher risk of COVID‐19 complications. JAMA. 2021;325:1027‐1028. doi:10.1001/jama.2021.2264
Wang Y, Liu Y. Multilevel determinants of COVID‐19 vaccination hesitancy in the United States: a rapid systematic review. Prev Med Rep. 2021;25:101673. doi:10.1016/j.pmedr.2021.101673
UNICEF. 2020 Humanitarian programme recommendations for COVID‐19 based on social sciences evidence from the DRC Ebola outbreak response. Social science support for COVID‐19: lessons learned brief 3. Cellule d'Analyse en Sciences Sociales (CASS). https://www.unicef.org/drcongo/media/4131/file/CASS‐Brief3‐recommendations.pdf
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377‐381. doi:10.1016/j.jbi.2008.08.010
Rana K, Poudel P, Chimoriya R. Qualitative methodology in translational Health Research: current practices and future directions. Healthcare (Basel). 2023;11:2665. doi:10.3390/healthcare11192665
Noy C. Sampling knowledge: the hermeneutics of snowball sampling in qualitative research. Int J Soc Res Methodol. 2008;11:327‐344. doi:10.1080/13645570701401305
Kane SP. Post‐hoc Power Calculator. 2023 https://clincalc.com/stats/power.aspx
Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women—United States, 2016–17 influenza season. MMWR Morb Mortal Wkly Rep. 2017;66:1016‐1022. doi:10.15585/mmwr.mm6638a2
Rio Grande do Sul SdSS. Informe Epidemiológico da Vigilância de Influenza Porto Alegre2016. 2016 https://coronavirus.rs.gov.br/informe‐epidemiologico
Kiefer MK, Mehl R, Costantine MM, et al. Characteristics and perceptions associated with COVID‐19 vaccination hesitancy among pregnant and postpartum individuals: a cross‐sectional study. BJOG. 2022;129:1342‐1351. doi:10.1111/1471-0528.17110
Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior—a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS One. 2017;12:e0170550. doi:10.1371/journal.pone.0170550
Pham PN, Sharma M, Bindu KK, et al. Protective behaviors associated with gender during the 2018–2020 Ebola outbreak in eastern Democratic Republic of the Congo. JAMA Netw Open. 2022;5:e2147462. doi:10.1001/jamanetworkopen.2021.47462
Sutton D, D'Alton M, Zhang Y, et al. COVID‐19 vaccine acceptance among pregnant, breastfeeding, and non‐pregnant reproductive‐aged women. Am J Obstet Gynecol MFM. 2021;3:100403. doi:10.1016/j.ajogmf.2021.100403
Descamps A, Launay O, Bonnet C, Blondel B. Seasonal influenza vaccine uptake and vaccine refusal among pregnant women in France: results from a national survey. Hum Vaccin Immunother. 2020;16:1093‐1100. doi:10.1080/21645515.2019.1688035
Bioethics NCo. Public Health—The Nuffield Council on Bioethics. Nuffield Council on Bioethics; 2007.
Giubilini A, Caviola L, Maslen H, et al. Nudging immunity: the case for vaccinating children in school and day care by default. HEC Forum. 2019;31:325‐344. doi:10.1007/s10730-019-09383-7
Ellington S, Olson CK. Safety of mRNA COVID‐19 vaccines during pregnancy. Lancet Infect Dis. 2022;22:1514‐1515. doi:10.1016/S1473-3099(22)00443-1
World Health Organization. COVID‐19 and Mandatory Vaccination: Ethical Considerations and Caveats: Policy Brief, 13 April 2021. WHO. 2021. https://www.who.int/publications/i/item/WHO‐2019‐nCoV‐Policy‐brief‐Mandatory‐vaccination‐2022.1
World Health Organization. Behavioural Considerations for Acceptance and Uptake of COVID‐19 Vaccines: WHO Technical Advisory Group on Behavioural Insights and Sciences for Health, meeting report, 15 October 2020. WHO; 2020. https://www.who.int/publications/i/item/9789240016927
Corcoran KE, Scheitle CP, DiGregorio BD. Christian nationalism and COVID‐19 vaccine hesitancy and uptake. Vaccine. 2021;39:6614‐6621. doi:10.1016/j.vaccine.2021.09.074
Brazilian Institute of Geography and Statistics (IBGE). Censo Brasileiro de 2010 Rio de janeiro. 2012. https://www.ibge.gov.br/
Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33:6420‐6429. doi:10.1016/j.vaccine.2015.08.046
Scales D, Gorman J, Jamieson KH. The Covid‐19 Infodemic—applying the epidemiologic model to counter misinformation. N Engl J Med. 2021;385:678‐681. doi:10.1056/NEJMp2103798
Ferigato S, Fernandez M, Amorim M, Ambrogi I, Fernandes LMM, Pacheco R. The Brazilian Government's mistakes in responding to the COVID‐19 pandemic. Lancet. 2020;396:1636. doi:10.1016/S0140-6736(20)32164-4
Koltai K, Moran RE, Buckley N, Kumar SD, Klentschy C. Vaccine “shedding” narratives targeted toward women—The Virality Project. 2021 https://www.viralityproject.org/rapid‐response/vaccine‐shedding‐narratives‐targeted‐toward‐women
Sadarangani M, Soe P, Shulha HP, et al. Safety of COVID‐19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet Infect Dis. 2022;22:1553‐1564. doi:10.1016/S1473-3099(22)00426-1
Moro PL, Olson CK, Clark E, et al. Post‐authorization surveillance of adverse events following COVID‐19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020–October 2021. Vaccine. 2022;40:3389‐3394. doi:10.1016/j.vaccine.2022.04.031
Marcell L, Dokania E, Navia I, et al. One vax two lives: a social media campaign and research program to address COVID‐19 vaccine hesitancy in pregnancy. Am J Obstet Gynecol. 2022;227:685‐695.e2. doi:10.1016/j.ajog.2022.06.022
Wollburg P, Markhof Y, Kanyanda S, Zezza A. Assessing COVID‐19 vaccine hesitancy and barriers to uptake in sub‐Saharan Africa. Commun Med (Lond). 2023;3:121. doi:10.1038/s43856-023-00330-9